Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.47 |
| ▸ | MDM4 | O15151 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CPB1 | P15086 | 1/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.45 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31389333 | 0.95 | TLR2 (0.51) | TLR2KMT2ACPB1CPB2PTPN1 | |
| SCHEMBL29657651 | 0.93 | TLR2 (0.54) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL30425443 | 0.93 | KMT2A (0.59) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL29445594 | 0.93 | KMT2A (0.59) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL31212512 | 0.92 | TLR2 (0.59) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL25356641 | 0.92 | KMT2A (0.55) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL119468 | 0.92 | KMT2A (0.55) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL31647336 | 0.92 | KMT2A (0.55) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL13401519 | 0.92 | KMT2A (0.55) | TLR2KMT2AMDM2MDM4TP53 | |
| SCHEMBL29569815 | 0.92 | KMT2A (0.55) | TLR2KMT2AMDM2MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028938-A | Pharmaceutical combination comprising an anti-CD 37 antibody maytansinoid conjugate and a BCL2 inhibitor or PI3K inhibitor | 德彪药业国际股份公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-119255824-A | Ligand-drug conjugates with improved pharmacokinetic and drug release profiles | 德比欧药物研究有限公司 | 2025-01-03 | — | — | CN | disclosed |